Literature DB >> 22162363

Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells.

Junfeng Ji1, Siemon H Ng, Vivek Sharma, Dante Neculai, Samer Hussein, Michelle Sam, Quang Trinh, George M Church, John D McPherson, Andras Nagy, Nizar N Batada.   

Abstract

Mutations in human induced pluripotent stem cells (iPSCs) pose a risk for their clinical use due to preferential reprogramming of mutated founder cell and selection of mutations during maintenance of iPSCs in cell culture. It is unknown, however, if mutations in iPSCs are due to stress associated with oncogene expression during reprogramming. We performed whole exome sequencing of human foreskin fibroblasts and their derived iPSCs at two different passages. We found that in vitro passaging contributed 7% to the iPSC coding point mutation load, and ultradeep amplicon sequencing revealed that 19% of the mutations preexist as rare mutations in the parental fibroblasts suggesting that the remaining 74% of the mutations were acquired during cellular reprogramming. Simulation suggests that the mutation intensity during reprogramming is ninefold higher than the background mutation rate in culture. Thus the factor induced reprogramming stress contributes to a significant proportion of the mutation load of iPSCs.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22162363     DOI: 10.1002/stem.1011

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  90 in total

Review 1.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 2.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

Review 3.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

4.  Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.

Authors:  Izumi Horikawa; Kye-Yoon Park; Kazunobu Isogaya; Yukiharu Hiyoshi; Han Li; Katsuhiro Anami; Ana I Robles; Abdul M Mondal; Kaori Fujita; Manuel Serrano; Curtis C Harris
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

5.  iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations.

Authors:  Erika M Kwon; John P Connelly; Nancy F Hansen; Frank X Donovan; Thomas Winkler; Brian W Davis; Halah Alkadi; Settara C Chandrasekharappa; Cynthia E Dunbar; James C Mullikin; Paul Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

Review 6.  Somatic mutation load and spectra: A record of DNA damage and repair in healthy human cells.

Authors:  Natalie Saini; Dmitry A Gordenin
Journal:  Environ Mol Mutagen       Date:  2018-08-27       Impact factor: 3.216

7.  Low-Dose Irradiation Enhances Gene Targeting in Human Pluripotent Stem Cells.

Authors:  Seigo Hatada; Aparna Subramanian; Berhan Mandefro; Songyang Ren; Ho Won Kim; Jie Tang; Vincent Funari; Robert H Baloh; Dhruv Sareen; Vaithilingaraja Arumugaswami; Clive N Svendsen
Journal:  Stem Cells Transl Med       Date:  2015-07-16       Impact factor: 6.940

8.  Influence of donor age on induced pluripotent stem cells.

Authors:  Valentina Lo Sardo; William Ferguson; Galina A Erikson; Eric J Topol; Kristin K Baldwin; Ali Torkamani
Journal:  Nat Biotechnol       Date:  2016-12-12       Impact factor: 54.908

Review 9.  Does transcription factor induced pluripotency accurately mimic embryo derived pluripotency?

Authors:  William E Lowry
Journal:  Curr Opin Genet Dev       Date:  2012-10-15       Impact factor: 5.578

10.  Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.

Authors:  Keiichiro Suzuki; Chang Yu; Jing Qu; Mo Li; Xiaotian Yao; Tingting Yuan; April Goebl; Senwei Tang; Ruotong Ren; Emi Aizawa; Fan Zhang; Xiuling Xu; Rupa Devi Soligalla; Feng Chen; Jessica Kim; Na Young Kim; Hsin-Kai Liao; Chris Benner; Concepcion Rodriguez Esteban; Yabin Jin; Guang-Hui Liu; Yingrui Li; Juan Carlos Izpisua Belmonte
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.